Infect Chemother.  2010 Jun;42(3):194-197. 10.3947/ic.2010.42.3.194.

Vancomycin-Resistant Enterococcus faecium Meningitis Treated with Linezolid: A Case Report and Review of the Literature

Affiliations
  • 1Department of Internal Medicine, Chonbuk National University Medical School and Research Institute of Clinical Medicine, Jeonju, Korea. lhbmd@chonbuk.ac.kr

Abstract

Vancomycin-resistant enterococci (VRE) infection is a serious problem because optimal therapy has not been established. Different agents in various combinations, including teicoplanin, chloramphenicol, and quinupristin/dalfopristin, have been used to treat patients with VRE meningitis, but the efficacy of these agents is not satisfactory because of their limited ability to penetrate into the cerebrospinal fluid. We report a case of nosocomial vancomycin-resistant Enterococcus faecium meningitis in a patient with ventriculoperitoneal shunt that was successfully treated with linezolid. We will also review previously reported cases of vancomycin-resistant E. faecium meningitis treated by linezolid.

Keyword

Vancomycin; Enterococcus faecium; Meningitis; Linezolid

MeSH Terms

Acetamides
Chloramphenicol
Enterococcus
Enterococcus faecium
Humans
Linezolid
Meningitis
Oxazolidinones
Teicoplanin
Vancomycin
Ventriculoperitoneal Shunt
Acetamides
Chloramphenicol
Oxazolidinones
Teicoplanin
Vancomycin

Reference

1. Bayer AS, Seidel JS, Yoshikawa TT, Anthony BF, Guze LB. Group D Enterococcal meningitis. Clinical and therapeutic considerations with report of three cases and review of the literature. Arch Intern Med. 1976. 136:883–886.
Article
2. Shin JW, Yong D, Kim MS, Chang KH, Lee K, Kim JM, Chong Y. Sudden increase of vancomycin-resistant enterococcal infections in a Korean tertiary care hospital: possible consequences of increased use of oral vancomycin. J Infect Chemother. 2003. 9:62–67.
Article
3. Evans GA. The Oxazolidinones. Curr Infect Dis Rep. 2002. 4:17–27.
Article
4. Huycke MM, Sahm DF, Gilmore MS. Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerg Infect Dis. 1998. 4:239–249.
Article
5. Shaikh ZH, Peloquin CA, Ericsson CD. Successful treatment of vancomycin-resistant Enterococcus faecium meningitis with linezolid: case report and literature review. Scand J Infect Dis. 2001. 33:375–379.
6. Zeana C, Kubin CJ, Della-Latta P, Hammer SM. Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature. Clin Infect Dis. 2001. 33:477–482.
Article
7. Hachem R, Afif C, Gokaslan Z, Raad I. Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid. Eur J Clin Microbiol Infect Dis. 2001. 20:432–434.
Article
8. Steinmetz MP, Vogelbaum MA, De Georgia MA, Andrefsky JC, Isada C. Successful treatment of vancomycin-resistant enterococcus meningitis with linezolid: case report and review of the literature. Crit Care Med. 2001. 29:2383–2385.
Article
9. Tsai TN, Wu CP, Peng MY, Giian CF, Lee SY, Lu JJ. Short course of linezolid treatment for vancomycin-resistant Enterococcus faecium meningitis. Int J Clin Pract. 2006. 60:740–741.
Article
10. Kumar S, Kohlhoff S, Valencia G, Hammerschlag MR, Sharma R. Treatment of vancomycin-resistant Enterococcus faecium ventriculitis in a neonate. Int J Antimicrob Agents. 2007. 29:740–741.
Article
11. Mizell KN, Carter JE. Vancomycin-resistant Enterococcus faecium meningitis successfully treated with linezolid. South Med J. 2008. 101:569–570.
Article
12. Ryu WS, Bae EK, Kim JS, Erm GH, Jung KH, Park HK, Chu K. Vancomycin-resistant Enterococcus meningitis. J Korean Neurol Assoc. 2008. 26:273–276.
13. Losonsky GA, Wolf A, Schwalbe RS, Nataro J, Gibson CB, Lewis EW. Successful treatment of meningitis due to multiply resistant Enterococcus faecium with a combination of intrathecal teicoplanin and intravenous antimicrobial agents. Clin Infect Dis. 1994. 19:163–165.
Article
14. Nachman SA, Verma R, Egnor M. Vancomycin-resistant Enterococcus faecium shunt infection in an infant: an anti-biotic cure. Microb Drug Resist. 1995. 1:95–96.
Article
15. Tush GM, Huneycutt S, Phillips A, Ward JD. Intraventricular quinupristin/dalfopristin for the treatment of vancomycin-resistant Enterococcus faecium shunt infection. Clin Infect Dis. 1998. 26:1460–1461.
Article
16. Williamson JC, Glazier SS, Peacock JE Jr. Successful treatment of ventriculostomy-related meningitis caused by vancomycin-resistant Enterococcus with intravenous and intraventricular quinupristin/dalfopristin. Clin Neurol Neurosurg. 2002. 104:54–56.
Article
17. Tan TY, Pitman I, Penrose-Stevens A, Simpson BA, Flanagan PG. Treatment of a vancomycin-resistant Enterococcus faecium ventricular drain infection with quinupristin/dalfopristin and review of the literature. J Infect. 2000. 41:95–97.
18. Tarasi A, Dever LL, Tomasz A. Activity of quinupristin/dalfopristin against Streptococcus pneumoniae in vitro and in vivo in the rabbit model of experimental meningitis. J Antimicrob Chemother. 1997. 39:Suppl A. 121–127.
Article
Full Text Links
  • IC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr